JNCCN 360

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Chrysalyne Schmults, MD, on Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma: Treatment Pipeline

Eve Maubec, MD, PhD, on Cutaneous Squamous Cell Carcinoma: Update on Trials

Chrysalyne Schmults, MD, on Basal Cell Carcinoma: Treatment Research Update

Recent

FDA Accepts sBLAs for 6-Week Dosing Schedule of Pembrolizumab for Merkel Cell Carcinoma

Cemiplimab-rwlc Approved for Advanced Cutaneous Squamous Cell Carcinoma in European Union

Secondary Skin Cancer and BTK Inhibitors for CLL

ICML 2019: Improved Outcomes With Brentuximab Vedotin in Cutaneous Lymphoma

Published

Medical Literature

Use of Avelumab in Merkel Cell Carcinoma: Linking Early Response With Overall Survival

Meta-analysis of Treatment of Skin Cancers With PD-1/PD-L1 Inhibitors

Quality of Life With Vismodegib Treatment of Non-Melanoma Skin Cancers

Standardized Total Body Skin Exam: Improved Accuracy and Efficiency?

Ongoing

New Treatments, New Data! Focus on Cutaneous Squamous Cell Carcinoma (login required)

Dermatologic Oncology Update, Issue 1, 2018

How to Effectively Manage Patients With Cutaneous Squamous Cell Carcinoma: Live From ASCO (login required)

Immunotherapy for cSCC: How, Why, and When (login required)

Available

Clinical Trials

University of Colorado Cancer Center

Siteman Cancer Center

Duke Cancer Institute

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.